Buckhorn
Senior member
- Joined
- Jan 3, 2016
- Messages
- 730
- Reason
- Lost a loved one
- Diagnosis
- 12/2015
- Country
- US
- State
- PA
- City
- Small town
These are the most recent articles I could find about the status of this drug trial:
Randomized phase 2 trial of NP001?a novel immune regulator: Safety and early efficacy in ALS
Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals? NP001 Potential Efficacy and
April 4, 2016 ? Neuraltus Pharmaceuticals, Inc.
Randomized phase 2 trial of NP001?a novel immune regulator: Safety and early efficacy in ALS
Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals? NP001 Potential Efficacy and
April 4, 2016 ? Neuraltus Pharmaceuticals, Inc.
